Correlated with their respective SMN protein level, both m6A dot-blot and LC-MS/MS detected reduced m6A levels in clinically affected SMA patient fibroblast cells, with GM09677 (most severe form of SMA) being the lowest (Fig. 4E,F). This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.